An oral quinoline derivative, MPT0B392, causes leukemic cells mitotic arrest and overcomes drug resistant cancer cells

Despite great advances in the treatment of acute leukemia, a renaissance of current chemotherapy needs to be improved. The present study elucidates the underlying mechanism of a new synthetic quinoline derivative, MPT0B392 (B392) against acute leukemia and its potential anticancer effect in drug res...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Chao, Min-Wu, Huang, Han-Li, HuangFu, Wei-Chun, Hsu, Kai-Cheng, Liu, Yi-Min, Wu, Yi-Wen, Lin, Chao-Feng, Chen, Yi-Lin, Lai, Mei-Jung, Lee, Hsueh-Yun, Liou, Jing-Ping, Teng, Che-Ming, Yang, Chia-Ron
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5438607/
https://ncbi.nlm.nih.gov/pubmed/28186963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15115
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados